BioAdaptives, Inc.’s Board of Directors Approves a One-for-One Stock Dividend
BioAdaptives Inc. (OTC: BDPT) has announced a one-for-one stock dividend approved by its Board of Directors. Shareholders will receive one additional share of common stock for each share owned as of the record date, which is projected for the second week of January 2025. The payment will be distributed within 15 days from the Record Date. CEO James Keener emphasized that this dividend aims to acknowledge shareholders' support and enhance stakeholder value.
BioAdaptives Inc. (OTC: BDPT) ha annunciato un dividendo azionario uno a uno approvato dal suo Consiglio di Amministrazione. Gli azionisti riceveranno un'ulteriore azione ordinaria per ogni azione posseduta alla data di registrazione, prevista per la seconda settimana di gennaio 2025. Il pagamento sarà distribuito entro 15 giorni dalla Data di Registrazione. Il CEO James Keener ha sottolineato che questo dividendo mira a riconoscere il supporto degli azionisti e a migliorare il valore per gli stakeholder.
BioAdaptives Inc. (OTC: BDPT) ha anunciado un dividendo de acciones uno a uno aprobado por su Junta Directiva. Los accionistas recibirán una acción adicional de acciones ordinarias por cada acción que posean a partir de la fecha de registro, que se proyecta para la segunda semana de enero de 2025. El pago se distribuirá dentro de los 15 días posteriores a la Fecha de Registro. El CEO James Keener enfatizó que este dividendo tiene como objetivo reconocer el apoyo de los accionistas y mejorar el valor para las partes interesadas.
BioAdaptives Inc. (OTC: BDPT)는 이사회에서 승인한 1:1 주식 배당금을 발표했습니다. 주주들은 기록일 기준으로 보유한 주식 1주당 추가로 1주의 보통주를 받게 됩니다. 기록일은 2025년 1월 두 번째 주로 예상됩니다. 지급은 기록일로부터 15일 이내에 이루어질 예정입니다. CEO 제임스 키너는 이 배당금이 주주들의 지지에 대한 감사의 뜻을 전하고 이해관계자의 가치를 높이기 위한 것이라고 강조했습니다.
BioAdaptives Inc. (OTC: BDPT) a annoncé un dividende d'actions en un pour un approuvé par son conseil d'administration. Les actionnaires recevront une action ordinaire supplémentaire pour chaque action détenue à la date d'enregistrement, prévue pour la deuxième semaine de janvier 2025. Le paiement sera effectué dans les 15 jours suivant la date d'enregistrement. Le PDG James Keener a souligné que ce dividende vise à reconnaître le soutien des actionnaires et à accroître la valeur pour les parties prenantes.
BioAdaptives Inc. (OTC: BDPT) hat eine eins zu eins Aktiendividende angekündigt, die von seinem Vorstand genehmigt wurde. Aktionäre erhalten eine zusätzliche Stammaktie für jede gehaltene Aktie zum Stichtag, der für die zweite Januarwoche 2025 angesetzt ist. Die Zahlung wird innerhalb von 15 Tagen nach dem Stichtag verteilt. CEO James Keener betonte, dass diese Dividende darauf abzielt, die Unterstützung der Aktionäre anzuerkennen und den Wert für die Interessengruppen zu steigern.
- One-for-one stock dividend approval, doubling shareholders' position
- Clear timeline for dividend distribution with specific record and payment dates
- Stock dividend may lead to share value dilution
- No cash dividend distribution, only stock-based compensation
LAS VEGAS, Dec. 03, 2024 (GLOBE NEWSWIRE) -- via IBN – BioAdaptives Inc. (OTC: BDPT) Board of Directors has approved a dividend to all common stockholders. They will receive matching shares for all of the shares they own on the Record Date.
CEO James Keener stated, “This dividend is designed to acknowledge your steadfast belief in our vision and to reward you for standing by us as valued stakeholders.”
Key Details:
- Dividend Structure: One additional share of common stock for each share owned as of the record date.
- Record Date: Projected for the second week of January 2025
- Payment Date: Within 15 days from the Record Date
Keener added, “This special dividend aligns with our dedication to enhancing shareholder value while reinforcing our focus on long-term growth and success. The additional shares you will receive signify our shared optimism for the future and our determination to deliver results that benefit all stakeholders.”
About BioAdaptives, Inc.
BioAdaptives, Inc. (OTC: BDPT) is a leader in the nutritional products industry, committed to delivering innovative solutions that enhance quality of life, anti-aging, cell repair, and well-being. With a deep focus on research, customer insights, and sustainable practices, BioAdaptives Inc. redefines what customers can expect from nutritional products. For more information, visit www.bioadaptives.com.
Forward-Looking Statements:
This press release contains forward-looking statements, including those related to the anticipated performance and success of the new product line. These statements are subject to risks and uncertainties that could materially cause actual results to differ. Please refer to our filings with the Securities and Exchange Commission for more information on potential risks.
Contact:
Emily Harrison
Investor Relations
BioAdaptives, Inc.
(702) 659-8829
Info@bioadaptives.com
Wire Service Contact:
IBN
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
Editor@InvestorBrandNetwork.com
FAQ
What is the stock dividend ratio announced by BioAdaptives (BDPTD)?
When is the record date for BioAdaptives (BDPTD) stock dividend?
When will BioAdaptives (BDPTD) pay the stock dividend?
How many additional shares will BDPTD shareholders receive?
